# MAY -6 765

# 510(k) Summary Beckman Coulter PARAGON CZE $\textsuperscript { \textregistered }$ 2000 Urine Protein Electrophoresis (UPE) Kit and Urine Immunofixation By Subtraction (U-IFE/s) Kit

# 1.0 Submitted By:

Kim Walker Regulatory Affairs Manager Beckman Coulter, Inc. 200 S. Kraemer Blvd., W-515 Brea, California 92822-8000 Telephone: (714) 961-4912 FAX: (714) 961-3969

# 2.0 Date Submitted:

January 14, 2005

# 3.0 Device Name(s):

3.1 Proprietary Names PARAGON CZE $\otimes$ 2000 Urine Protein Electrophoresis (UPE) Kit PARAGON CZE $\otimes$ 2000 Urine Immunofixation by Subtraction (U-IFE/s) Electrophoresis Kit

# 3.2 Classification Name

UPE & U-IFE/s - Bence-Jones proteins immunological test (21 CFR $\ S 8 6 6 . 5 1 5 0 \}$ EP

<table><tr><td rowspan=1 colspan=1>Candidate</td><td rowspan=1 colspan=1>Predicate</td><td rowspan=1 colspan=1>Manufacturer</td><td rowspan=1 colspan=1>DocketNumber</td></tr><tr><td rowspan=1 colspan=1>PARAGON CZE2000 UPE Kit</td><td rowspan=1 colspan=1>PARAGON SPE Kit</td><td rowspan=1 colspan=1>BeckmanCoulter, Inc.</td><td rowspan=1 colspan=1>K802592</td></tr><tr><td rowspan=1 colspan=1>PARAGON CZE2000 U-IFE/s Kit</td><td rowspan=1 colspan=1>PARAGON IFE Kit</td><td rowspan=1 colspan=1>BeckmanCoulter, Inc.</td><td rowspan=1 colspan=1>K823884</td></tr></table>

# 5.0 Description:

The PARAGON CZE $\textsuperscript { \textregistered }$ 2000 UPE and U-IFE/s kits are designed for optimal performance on the PARAGON CZE $\otimes$ 2000. The UPE kits contain one Segment package containing 20 Segments, five Desalting Column packages with 4 columns per package, and four 500 mL Desalting Reagent bottles. The U-IFE/s kits contain two Segment packages containing 10 Segments, one Desalting Column package with 4 columns per package, and one 500 mL Desalting Reagent bottle.

# 6.0 Intended Use:

The PARAGON CZE® 2000 Urine Protein Electrophoresis (UPE) Kit is intended for use with the Paragon CZE 2000 Capillary Electrophoresis System for the electrophoretic separation of proteins in human urine.

The PARAGON CZE $\otimes$ 2000 Urine Immunofixation by Subtraction (UIFE/s) Electrophoresis Kit is intended for use with the Paragon CZE 2000 Capillary Electrophoresis System for the immunologic identification of monoclonal components in human urine.

# 7.0 Comparison to Predicate(s):

The following tables show similarities and differences between the predicate identified in Section 4.0 of this summary.

Similarities to the Predicate   

<table><tr><td rowspan=1 colspan=1>Kit</td><td rowspan=1 colspan=1>Aspect/Characteristic</td><td rowspan=1 colspan=1>Comments</td></tr><tr><td rowspan=5 colspan=1>UPE Kit</td><td rowspan=1 colspan=1>Basic Technology (Electrophoretic Migration)</td><td rowspan=5 colspan=1>Same as BeckmanParagon SPE Kit</td></tr><tr><td rowspan=1 colspan=1>Urine Sample Type</td></tr><tr><td rowspan=1 colspan=1>Shelf Life Stability</td></tr><tr><td rowspan=1 colspan=1>Specificity</td></tr><tr><td rowspan=1 colspan=1>Qualitative Results</td></tr><tr><td rowspan=6 colspan=1>U-IFE/s Kit</td><td rowspan=1 colspan=1>Basic Technology (Electrophoretic Migrationwith Immunofixation)</td><td rowspan=6 colspan=1>Same as BeckmanParagon IFE Kit</td></tr><tr><td rowspan=1 colspan=1>Urine Sample Type</td></tr><tr><td rowspan=1 colspan=1>Qualitative Results</td></tr><tr><td rowspan=1 colspan=1>Shelf Life Stability</td></tr><tr><td rowspan=1 colspan=1>Antisera Storage</td></tr><tr><td rowspan=1 colspan=1>Antisera Specificity</td></tr></table>

# Differences From The Predicate

<table><tr><td colspan="1" rowspan="1">Kit</td><td colspan="1" rowspan="1">Aspect/Characteristic</td><td colspan="1" rowspan="1">Comments</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="8">UPE Kit</td><td colspan="1" rowspan="1">Intended Use</td><td colspan="1" rowspan="1">The Paragon CZE 2000 Urine Protein Electrophoresis(UPE) Kit is intended for use with the Paragon CZE2000 Capillary Electrophoresis System for theelectrophoretic separation of proteins in human urine.The Paragon Serum Protein Electrophoresis (SPE) Kitis intended for the electrophoretic separation ofproteins in human serum, cerebrospinal fluid, andurine.</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Sample Preparation</td><td colspan="1" rowspan="1">UPE - No concentration required for urine sampleswith a total protein of 20-4800 mg/dL. Must desaltbefore running sample on CZE. Any samples &lt;20mg/dL must be concentrated and &gt;4800 mg/dL mustbe diluted.SPE - Concentration required for all urine samples&lt;700 mg/dL total protein.</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Interferences</td><td colspan="1" rowspan="1">UPE- Any materials that would absorb at 214 nm andnot removed by desalting. Hemoglobin co-migrateswith transferrin.SPE - Lipemic and hemolyzed samples.</td><td></td></tr><tr><td colspan="1" rowspan="1">Lowest DetectibleLimit</td><td colspan="1" rowspan="1">UPE - 0.5-2.0 mg/dL of Kappa and Lambda BenceJones Proteins were visible when no other co-migrating proteins were present.SPE - No claims made.</td><td></td></tr><tr><td colspan="1" rowspan="1">Methodology</td><td colspan="1" rowspan="1">UPE  Capillary ElectrophoresisSPE - Gel Electrophoresis</td><td></td></tr><tr><td colspan="1" rowspan="1">Sample Size</td><td colspan="1" rowspan="1">UPE - 0.5 mL Desalted UrineSPE - 3-5 uL Concentrated or Neat Urine</td><td></td></tr><tr><td colspan="1" rowspan="1">StorageTemperature</td><td colspan="1" rowspan="1">UPE- 2 - 30CSPE - 18 - 26</td><td></td></tr><tr><td colspan="1" rowspan="1">Analytic Range</td><td colspan="1" rowspan="1">UPE - Single Protein Component 0.5 - 2.0 mg/dL to4600 mg/dL &amp; Total Protein 0.02 - 4.80 g/dLSPE - Total Protein &gt;700 mg/dL</td><td></td></tr><tr><td colspan="1" rowspan="1">Kit</td><td colspan="1" rowspan="1">Aspect/Characteristic</td><td colspan="1" rowspan="1">Comments</td></tr><tr><td colspan="1" rowspan="8">U-IFE/sKit</td><td colspan="1" rowspan="1">Intended Use</td><td colspan="1" rowspan="1">The Paragon CZE 2000 Urine Immunofixation bySubtraction (U-IFE/s) Electrophoresis Kit is intendedfor use with the Paragon CZE 2000 CapillaryElectrophoresis System for the immunologicidentification of monoclonal components in humanurine.The Paragon Immunofixation Electrophoresis (IFE) Kitis for the immunologic identification of proteins inhuman serum, cerebrospinal fluid, and urine.</td></tr><tr><td colspan="1" rowspan="1">Sample Preparation</td><td colspan="1" rowspan="1">U-IFE/s - No concentration required for urine samplesw/ monoclonal components of 5 - 300 mg/dL. Mustdesalt before running sample on CZE. Any samples&lt;5 mg/dL of monoclonal components or &lt;2.5 - 10.0mg/dL of monoclonal components must beconcentrated &amp; &gt;300 mg/dL of monoclonalcomponents must be diluted.IFE - Concentration required for all urine samples&lt;100 mg/dL total protein for the detection of Bence-Jones Proteins. Concentration up to 800 - 1000mg/dL should be conducted on all urine samples forthe detection of immunoglobulins.</td></tr><tr><td colspan="1" rowspan="1">Interferences</td><td colspan="1" rowspan="1">U-IFE/s- Any materials that would absorb at 214 nmand not removed by desalting. Hemoglobin co-migrates w/ transferrin.IFE - Fibrinogen containing, IgM Immune complexcontaining &amp; hemolyzed samples.</td></tr><tr><td colspan="1" rowspan="1">Lowest DetectibleLimit</td><td colspan="1" rowspan="1">U-IFE/s - 2.5-5.0 mg/dL of Lambda &amp; 5.0-10.0 mg/dLof Kappa Bence-Jones proteins were visible when noother co-migrating proteins were present.IFE - No claims made.</td></tr><tr><td colspan="1" rowspan="1">Methodology</td><td colspan="1" rowspan="1">U-IFE/s - Capillary ElectrophoresisIFE - Gel Electrophoresis</td></tr><tr><td colspan="1" rowspan="1">Sample Size</td><td colspan="1" rowspan="1">U-IFE/s - 300-700 uL. Desalted Urine depending onthe dilution usedIFE - 3-5 uL Concentrated or Neat Urine</td></tr><tr><td colspan="1" rowspan="1">StorageTemperature otherthan Antisera</td><td colspan="1" rowspan="1">U-IFE/s - 2 - 30CIFE - 18 - 26C</td></tr><tr><td colspan="1" rowspan="1">Analytic Range</td><td colspan="1" rowspan="1">U-IFE/s - 2.5 - 5.0 mg/dL to 300 mg/dL Lambda &amp; 5.0- 10.0 mg/dL to 300 mg/dL KappaIFE - Total Protein &gt;100 mg/dL for detection of Bence-Jones Proteins. Total Protein &gt;800-1000 mg/dL fordetection of immunoglobulins.</td></tr></table>

The data in the Premarket Notification on safety and effectiveness supports a finding of substantial equivalence to chemistry test systems already in commercial distribution. Equivalence is demonstrated through method comparison, stability, linearity/sensitivity, and precision/ reproducibility experiments.

Method Comparison Study Results   

<table><tr><td rowspan=1 colspan=1>Instrument</td><td rowspan=1 colspan=1>Agreement</td><td rowspan=1 colspan=1>PartialAgreement</td><td rowspan=1 colspan=1>Disagreement</td><td rowspan=1 colspan=1>n</td><td rowspan=1 colspan=1>ComparisonMethod</td></tr><tr><td rowspan=1 colspan=1>PARAGONCZE 2000- UPE Kit</td><td rowspan=1 colspan=1>95</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>PARAGON GelElectrophoresis SPE Kit</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Instrument</td><td rowspan=1 colspan=1>Full Agreement</td><td rowspan=1 colspan=1>Disagreement</td><td rowspan=1 colspan=1>n</td><td rowspan=1 colspan=1>Comparison Method</td></tr><tr><td rowspan=1 colspan=1>PARAGONCZE 2000-U-IFE/sKit</td><td rowspan=1 colspan=1>76(92.7%)</td><td rowspan=1 colspan=1>6(7.3%)</td><td rowspan=1 colspan=1>82</td><td rowspan=1 colspan=1>PARAGON GelElectrophoresis — IFEKit</td></tr></table>

# UPE Imprecision Results

<table><tr><td rowspan=1 colspan=1>Type ofImprecision</td><td rowspan=1 colspan=1>Sample</td><td rowspan=1 colspan=1>Fraction</td><td rowspan=1 colspan=1>Mean(Relative %)</td><td rowspan=1 colspan=1>S.D.(Relative %)</td><td rowspan=1 colspan=1>%C.V.</td><td rowspan=1 colspan=1>N</td></tr><tr><td rowspan=1 colspan=7>Within-Run Imprecision</td></tr><tr><td rowspan=2 colspan=1>SystemReproducibility</td><td rowspan=2 colspan=1>UrinePool</td><td rowspan=1 colspan=1>Albumin</td><td rowspan=1 colspan=1>55.1</td><td rowspan=1 colspan=1>1.38</td><td rowspan=1 colspan=1>2.5</td><td rowspan=1 colspan=1>21</td></tr><tr><td rowspan=1 colspan=1>BJP</td><td rowspan=1 colspan=1>13.2</td><td rowspan=1 colspan=1>0.93</td><td rowspan=1 colspan=1>7.1</td><td rowspan=1 colspan=1>21</td></tr><tr><td rowspan=2 colspan=1>DesaltingReproducibility</td><td rowspan=2 colspan=1>UrinePool</td><td rowspan=1 colspan=1>Albumin</td><td rowspan=1 colspan=1>54.8</td><td rowspan=1 colspan=1>1.65</td><td rowspan=1 colspan=1>3.0</td><td rowspan=1 colspan=1>21</td></tr><tr><td rowspan=1 colspan=1>BJP</td><td rowspan=1 colspan=1>13.5</td><td rowspan=1 colspan=1>0.71</td><td rowspan=1 colspan=1>5.3</td><td rowspan=1 colspan=1>21</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td rowspan=1 colspan=7>Total Imprecision</td></tr><tr><td rowspan=6 colspan=1>Total(EP 10-A)</td><td rowspan=2 colspan=1>UrineLevel 1</td><td rowspan=1 colspan=1>Albumin</td><td rowspan=1 colspan=1>28.8</td><td rowspan=1 colspan=1>0.7</td><td rowspan=1 colspan=1>2.5</td><td rowspan=1 colspan=1>15</td></tr><tr><td rowspan=1 colspan=1>BJP</td><td rowspan=1 colspan=1>13.4</td><td rowspan=1 colspan=1>0.8</td><td rowspan=1 colspan=1>5.9</td><td rowspan=1 colspan=1>15</td></tr><tr><td rowspan=2 colspan=1>UrineLevel 2</td><td rowspan=1 colspan=1>Albumin</td><td rowspan=1 colspan=1>60.8</td><td rowspan=1 colspan=1>1.3</td><td rowspan=1 colspan=1>2.2</td><td rowspan=1 colspan=1>15</td></tr><tr><td rowspan=1 colspan=1>BJP</td><td rowspan=1 colspan=1>6.5</td><td rowspan=1 colspan=1>0.8</td><td rowspan=1 colspan=1>12.7</td><td rowspan=1 colspan=1>15</td></tr><tr><td rowspan=2 colspan=1>UrineLevel 3</td><td rowspan=1 colspan=1>Albumin</td><td rowspan=1 colspan=1>9.2</td><td rowspan=1 colspan=1>0.8</td><td rowspan=1 colspan=1>9.2</td><td rowspan=1 colspan=1>15</td></tr><tr><td rowspan=1 colspan=1>BJP</td><td rowspan=1 colspan=1>72.1</td><td rowspan=1 colspan=1>1.5</td><td rowspan=1 colspan=1>2.0</td><td rowspan=1 colspan=1>15</td></tr></table>

# U-IFE/s Reproducibility Results

The electropherograms were visually inspected to ensure that at least $80 \%$ were within agreement. No observable difference in morphology or subtraction was seen between the segments for each of the samples tested. BJP subtraction with kappa and lambda was as expected. Reproducibility meets the $80 \%$ specification for visual agreement for the replicate segments.

This summary of safety and effectiveness is being submitted in accordance with the requirements of the Safe Medical Device Act of 1990 and the implementing regulation 21 CFR 807.92.

![](images/0403c2df9aad32a18f2b72f633daaae5f697a2eba450744522a5374a6a42fc50.jpg)

# MAY - 6 2005

Ms. Kim Walker, RAC Regulatory Affairs Manager Beckman Coulter, Inc. 200 S. Kraemer Boulevard M/S W-515 Brea, California 92822-8000

Re: k050119 Trade/Device Name: PARAGON CZE $^ \mathrm { \textregistered }$ 2000 Urine Protein Electrophoresis (UPE) Kit and Urine Immunofixation by Subtraction (U-IFE/s) Kit Regulation Number: 21 CFR $\$ 866.5150$ EPY Regulation Name: Bence-Jones proteins immunological test Regulatory Class: II Product Code: JKM, CFF, DFH, DEH Dated: March 30, 2005 Received: March 31, 2005

Dear Ms Walker:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820). This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

Page 2 -

If you desire specific information about the application of labeling requirements to your device, or questions on the promotion and advertising of your device, please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (240) 276-0484. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address   
http://www.fda.gov/cdrh/industry/support/index.html

Sincerely yours,

Robuth Beckter

Robert L. Becker, Jr., MD, PH.D   
Director   
Division of Immunology and Hematology   
Office of In Vitro Diagnostic Device   
Evaluation and Safety   
Center for Devices and   
Radiological Health

# Indications for Use

510(k) Number (if known): EY $1 \times 0 5 0 1 1 9$

Device Name:

# PARAGON CZE $\pmb { \bigotimes }$ 2000 Urine Protein Electrophoresis (UPE) Kit and Urine Immunofixation By Subtraction (UFE/s) Kit

Indications for Use:

The PARAGON CZE® 2000 Urine Protein Electrophoresis (UPE) Kit is intended for use with the Paragon CZE 2000 Capillary Electrophoresis System for the electrophoretic separation of proteins in human urine.

The PARAGON CZE $\otimes$ 2000 Urine Immunofixation by Subtraction (U-iFE/s) Electrophoresis Kit is intended for use with the Paragon CZE 2000 Capillary Electrophoresis System for the immunologic identification of monoclonal components in human urine.

# (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of In Vitr9 Diagnostic Devices (OIVD)   
Divisiu Signg.off   
Office of In Vitre Diagnostic Device Page 1 of   
Evaluation and Safety   
510(k) K050119